1.060USD+4.95%Mkt Cap: 30.68M USDP/E: —Last update: 2026-06-01
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBa…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap30.68M USD
Enterprise Value98.07M USD
Revenue (TTM)26.55M USD
Gross Profit6.48M USD
Net Income (TTM)-91.72M USD
Revenue/Share1.037 USD
Last Price1.060 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.77
PEG—
EV/EBITDA-1.82
EV/Revenue3.69
P/S1.10
P/B-0.77
EPS (TTM)-3.59
EPS (Forward)-0.57
52W Range
0.710010% of range4.350
52W High4.350 USD
52W Low0.7100 USD
Profitability
Gross Margin24.39%
Oper. Margin-492.15%
EBITDA Margin-203.44%
Profit Margin-345.45%
ROE240.96%
ROA-85.45%
Growth
Revenue Growth-77.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.25M USD
CapEx (TTM)—
FCF Margin20.28%
FCF Yield17.55%
Net Debt68.54M USD
Net Debt/EBITDA-1.27
Balance Sheet
Debt/Equity-1.07
Current Ratio0.15
Quick Ratio0.14
Book Value/Sh-1.3200 USD
Cash/Share0.2130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateFeb 29, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.28.95M
Float18.87M
Insiders36.41%
Institutions12.77%
Short Interest
Short Ratio2.4d
Short % Float5.60%
Short % Out.1.29%
Shares Short373.20K
Short (prev mo.)226.43K
Technical
SMA 501.090 (-2.8%)
SMA 2001.664 (-36.3%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)166.60K
Avg Vol (10d)163.37K
Technical Indicators
RSI (14)56.7
MACD-0.0362
MACD Signal-0.0704
MACD Hist.+0.0342
BB Upper1.036 USD
BB Middle0.8802 USD
BB Lower0.7248 USD
BB Width35.32%
ATR (14)0.0767 USD
Vol Ratio (20d)0.29x